Search

Author/Creator Galanopoulos, Athanasios

11. The effect of 5‐azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes. (30th August 2020)

Authors:
Diamantopoulos, Panagiotis T.; Symeonidis, Argiris; Pappa, Vasiliki; Kotsianidis, Ioannis; Galanopoulos, Athanasios; Pontikoglou, Charalampos; Anagnostopoulos, Achilles; Vassilopoulos, George; Zikos, Panagiotis; Hatzimichael, Eleftheria; Papaioannou, Maria; Megalakaki, Aekaterini; Repousis, Panag...
Journal:
British journal of haematology
Issue:
Volume 192:Number 6(2021)
Page Start:
978
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry. (21st March 2019)

Authors:
Diamantopoulos, Panagiotis; Koumbi, Dafni; Kotsianidis, Ioannis; Pappa, Vasiliki; Symeonidis, Argiris; Galanopoulos, Athanasios; Zikos, Panagiotis; Papadaki, Helen A.; Panayiotidis, Panayiotis; Dimou, Maria; Hatzimichael, Eleftheria; Vassilopoulos, George; Delimpasis, Susan; Mparmparousi, Despoin...
Journal:
Cancer medicine
Issue:
Volume 8:Number 5(2019:May)
Page Start:
2056
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. The prognostic significance of macrocytosis in patients with myelodysplastic neoplasms. Issue 5 (1st March 2023)

Authors:
Diamantopoulos, Panagiotis T.; Solomou, Elena; Symeonidis, Argiris; Pappa, Vasiliki; Kotsianidis, Ioannis; Galanopoulos, Athanasios; Pontikoglou, Charalampos; Anagnostopoulos, Achilles; Vassilopoulos, George; Zikos, Panagiotis; Hatzimichael, Eleftheria; Papaioannou, Maria; Megalakaki, Aekaterini;...
Journal:
American journal of hematology
Issue:
Volume 98:Issue 5(2023)
Page Start:
E119
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. Upregulated hypoxia inducible factor 1α signaling pathway in high risk myelodysplastic syndrome and acute myeloid leukemia patients is associated with better response to 5‐azacytidine—data from the Hellenic myelodysplastic syndrome study group. Issue 2 (1st January 2021)

Authors:
Mpakou, Vassiliki; Spathis, Aris; Bouchla, Anthi; Tsakiraki, Zoi; Kontsioti, Frieda; Papageorgiou, Sotirios; Bazani, Efthymia; Gkontopoulos, Konstantinos; Thomopoulos, Thomas; Glezou, Irene; Galanopoulos, Athanasios; Symeonidis, Argiris; Diamantopoulos, Panagiotis T.; Viniou, Nora‐Athina; Kontand...
Journal:
Hematological oncology
Issue:
Volume 39:Issue 2(2021)
Page Start:
231
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗